Literature DB >> 15939352

Integrated bioprocesses.

Karl Schügerl1, Jürgen Hubbuch.   

Abstract

Integrated bioprocesses have been developed to optimise yield and cost-effectiveness of production of low and high molecular weight molecules. Low molecular weight products are removed from the cultivation medium with in situ extraction, in situ adsorption or crystallisation to avoid product inhibition. One-pot processes are being developed to replace two-stage reactions. Recent developments in the integrated purification of high molecular weight products focus mainly on the integration of solid/liquid separation and initial product recovery such as expanded bed adsorption or extraction in aqueous two-phase systems. Additionally, new approaches for a more efficient processing of inclusion bodies have been developed.

Mesh:

Year:  2005        PMID: 15939352     DOI: 10.1016/j.mib.2005.01.002

Source DB:  PubMed          Journal:  Curr Opin Microbiol        ISSN: 1369-5274            Impact factor:   7.934


  8 in total

1.  Soluble expression of pullulanase from Bacillus acidopullulyticus in Escherichia coli by tightly controlling basal expression.

Authors:  Ana Chen; Yamei Li; Xiuxia Liu; Quan Long; Yankun Yang; Zhonghu Bai
Journal:  J Ind Microbiol Biotechnol       Date:  2014-10-14       Impact factor: 3.346

2.  NADH availability limits asymmetric biocatalytic epoxidation in a growing recombinant Escherichia coli strain.

Authors:  Bruno Bühler; Jin-Byung Park; Lars M Blank; Andreas Schmid
Journal:  Appl Environ Microbiol       Date:  2008-01-11       Impact factor: 4.792

3.  Production of extracellular fatty acid using engineered Escherichia coli.

Authors:  Hui Liu; Chao Yu; Dexin Feng; Tao Cheng; Xin Meng; Wei Liu; Huibin Zou; Mo Xian
Journal:  Microb Cell Fact       Date:  2012-04-03       Impact factor: 5.328

4.  Pilot-scale process for magnetic bead purification of antibodies directly from non-clarified CHO cell culture.

Authors:  Nils A Brechmann; Per-Olov Eriksson; Kristofer Eriksson; Sven Oscarsson; Jos Buijs; Atefeh Shokri; Göran Hjälm; Véronique Chotteau
Journal:  Biotechnol Prog       Date:  2019-01-30

5.  Integrated autolysis, DNA hydrolysis and precipitation enables an improved bioprocess for Q-Griffithsin, a broad-spectrum antiviral and clinical-stage anti-COVID-19 candidate.

Authors:  John S Decker; Romel Menacho-Melgar; Michael D Lynch
Journal:  Biochem Eng J       Date:  2022-03-12       Impact factor: 3.978

6.  Recombinant Enzymatic Redox Systems for Preparation of Aroma Compounds by Biotransformation.

Authors:  Viktor Varga; Vladimír Štefuca; Lenka Mihálová; Zdenko Levarski; Eva Struhárňanská; Jaroslav Blaško; Robert Kubinec; Pavel Farkaš; Vladimír Sitkey; Ján Turňa; Michal Rosenberg; Stanislav Stuchlík
Journal:  Front Microbiol       Date:  2021-06-24       Impact factor: 5.640

7.  In situ magnetic separation of antibody fragments from Escherichia coli in complex media.

Authors:  Martin Cerff; Alexander Scholz; Matthias Franzreb; Iris L Batalha; Ana Cecilia A Roque; Clemens Posten
Journal:  BMC Biotechnol       Date:  2013-05-20       Impact factor: 2.563

8.  Improved Production and In Situ Recovery of Sesquiterpene (+)-Zizaene from Metabolically-Engineered E. coli.

Authors:  Francisco Aguilar; Thomas Scheper; Sascha Beutel
Journal:  Molecules       Date:  2019-09-15       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.